Hello, my name is Kai Henrikson-Brandt

I am a current sophomore at Johns Hopkins University studying Chemical & Biomolecular Engineering. I am on the Data Science & Machine Learning track and plan a minor in Entrepreneurship & Management. I am also a member of Johns Hopkins Swimming. This repo functions both as a centralized portfolio and as a space for me to organize my thoughts and notes on a variety of topics including the life sciences, engineering, business, but also philosophy, literature, and other miscellaneous reflections.

Repository Layout

archive/
├── biopharma_biotech/
│   ├── r&d/
│   └── business/
├── engineering/
├── misc/
│   ├── career/
│   ├── movies/
│   ├── philosophy/
│   ├── reading/
|   └── sport/
├── portfolio/
└── README.md

Current Interests

My outlook today is broad. After a summer bridging computational and wet-lab therapeutic peptide research, I find myself with hardly more clarity of what I want to do (or, perhaps more importantly, what I don't want to do) in the future. Today, therapeutic development continues to interest me, but the day-to-day of R&D left me with an itch for adding high-level, top-down strategy thinking, at least in the long-term. At Hopkins this year, I look forward to continuing work in therapeutic development, with particular interest in protein engineering, radiopharmaceuticals, and immunotherapy. I also will be continuing work at Genauris on the business, strategy, and operations side of healthcare and the life sciences. In the future, I hope to combine these interests, hopefully striking an intellectually stimulating bridge between driving innovation and the decisions that bring those innovations to fruition.

Experience

Financial Analyst & Strategy Intern - Genauris

Part-Time, January 2026 - Present

• Audited and restructured a 5-year operational P&L, synchronizing downstream labor, OPEX, and COGS forecasts across 7 global business units.
• Implemented dynamic scaling assumptions linking operational headcount to active user growth, preserving modeled cash runway during variable adoption.

Medicinal Chemistry Intern - NIH/NCATS (National Center for Advancing Translational Sciences)

Full-Time, June 2026 - August 2026

• Architected an end-to-end computational generation pipeline for optimized peptide analogs, incorporating biophysical and structural filters to reduce a candidate pool of 5,000 to 8 for synthesis.
• Managed the synthesis, resin cleavage, isolation, and characterization of analog peptides, driving the lead optimization process downstream to ADME, in vitro binding, and in vivo efficacy assays for promising candidates.